Market Research Logo

Global Cancer Pain Epidemiology and Patient Flow Analysis - 2017

Global Cancer Pain Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Cancer Pain patients study in a new report ‘Global Cancer Pain Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Cancer Pain epidemiology, Cancer Pain diagnosed patients, and Cancer Pain treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Cancer Pain derived from epidemiological analysis, percentage of patients diagnosed with Cancer Pain, and percentage of patients treated with a therapy.

The study helps executives estimate Cancer Pain market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Cancer Pain prevalence, Cancer Pain diagnosis rate, and Cancer Pain treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Cancer Pain Patient Flow
  • Cancer Pain Prevalence
  • Cancer Pain Diagnosed Patients
  • Cancer Pain Treated Patients


1. Cancer Pain: Disease Definition
2. Global Cancer Pain Patient Flow
2A. Global Cancer Pain Prevalence
2B. Global Cancer Pain Diagnosed Patients
2C. Global Cancer Pain Treated Patients
3. Cancer Pain Patient Flow in the US
3A. Cancer Pain Prevalence in the US
3B. Cancer Pain Diagnosed Patients in the US
3C. Cancer Pain Treated Patients in the US
4. Cancer Pain Patient Flow in Europe
4A. Cancer Pain Prevalence in Europe
4B. Cancer Pain Diagnosed Patients in Europe
4C. Cancer Pain Treated Patients in Europe
5. Cancer Pain Patient Flow in Germany
5A. Cancer Pain Prevalence in Germany
5B. Cancer Pain Diagnosed Patients in Germany
5C. Cancer Pain Treated Patients in Germany
6. Cancer Pain Patient Flow in France
6A. Cancer Pain Prevalence in France
6B. Cancer Pain Diagnosed Patients in France
6C. Cancer Pain Treated Patients in France
7. Cancer Pain Patient Flow in Spain
7A. Cancer Pain Prevalence in Spain
7B. Cancer Pain Diagnosed Patients in Spain
7C. Cancer Pain Treated Patients in Spain
8. Cancer Pain Patient Flow in Italy
8A. Cancer Pain Prevalence in Italy
8B. Cancer Pain Diagnosed Patients in Italy
8C. Cancer Pain Treated Patients in Italy
9. Cancer Pain Patient Flow in UK
9A. Cancer Pain Prevalence in UK
9B. Cancer Pain Diagnosed Patients in UK
9C. Cancer Pain Treated Patients in UK
10. Cancer Pain Patient Flow in Japan
10A. Cancer Pain Prevalence in Japan
10B. Cancer Pain Diagnosed Patients in Japan
10C. Cancer Pain Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Cancer Pain Patient Flow, 2016
Table 2: Global Cancer Pain Patient Flow Forecast, 2016 - 2025
Table 3: Cancer Pain Patient Flow in the US, 2016
Table 4: Cancer Pain Patient Flow Forecast in the US, 2016 - 2025
Table 5: Cancer Pain Patient Flow in Europe, 2016
Table 6: Cancer Pain Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Cancer Pain Patient Flow in Germany, 2016
Table 8: Cancer Pain Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Cancer Pain Patient Flow in France, 2016
Table 10: Cancer Pain Patient Flow Forecast in France, 2016 - 2025
Table 11: Cancer Pain Patient Flow in Spain, 2016
Table 12: Cancer Pain Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Cancer Pain Patient Flow in Italy, 2016
Table 14: Cancer Pain Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Cancer Pain Patient Flow in UK, 2016
Table 16: Cancer Pain Patient Flow Forecast in UK, 2016 - 2025
Table 17: Cancer Pain Patient Flow in Japan, 2016
Table 18: Cancer Pain Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Cancer Pain Patient Flow, 2016
Figure 2: Global Cancer Pain Patient Flow Forecast, 2016 - 2025
Figure 3: Cancer Pain Patient Flow in the US, 2016
Figure 4: Cancer Pain Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Cancer Pain Patient Flow in Europe, 2016
Figure 6: Cancer Pain Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Cancer Pain Patient Flow in Germany, 2016
Figure 8: Cancer Pain Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Cancer Pain Patient Flow in France, 2016
Figure 10: Cancer Pain Patient Flow Forecast in France, 2016 - 2025
Figure 11: Cancer Pain Patient Flow in Spain, 2016
Figure 12: Cancer Pain Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Cancer Pain Patient Flow in Italy, 2016
Figure 14: Cancer Pain Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Cancer Pain Patient Flow in UK, 2016
Figure 16: Cancer Pain Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Cancer Pain Patient Flow in Japan, 2016
Figure 18: Cancer Pain Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report